Unknown statusInterventionalNot ApplicableUpdated Jan 28, 2020
MEDCEM PC and MTA in Pulpotomies of Primary Molars | NCT02291120 | Trialant
Unknown statusInterventionalPhase 4Updated Nov 14, 2014
MEDCEM PC and MTA in Pulpotomies of Primary Molars
ClinicalTrials.gov ID
NCT02291120
Lead Sponsor
Universitat Internacional de CatalunyaOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Phase 4
Enrollment
80Estimated
Last Update Posted
Nov 14, 2014Estimated
Start Date
Mar 2014
Primary Completion Date
Oct 2015Estimated
Completion Date
Dec 2016Estimated
Brief Summary
The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MEDCEM PC and MTA when used as pulp dressings following pulpotomy in human primary molars.
Evaluate the Effects of MEDCEM PC and MTA in Pulpotomies of Primary Molars.
Pulpotomy
Ages Eligible for Study
Child (0-17)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
healthy children
molars showing: symptomless exposure of vital pulp by caries no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction) the possibility of proper restoration of the teeth no physiological resorption of more than one-third of the root
Exclusion Criteria:
presence of systemic pathology
history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents